camptothecin has been researched along with Kahler Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JS; Cui, G; DiPersio, JF; Fiala, MA; Fletcher, S; Fontana, F; Lanza, GM; O'Neal, J; Pan, D; Rettig, M; Ritchey, J; Schmieder-Atteberry, AH; Scott, MJ; Simons, K; Vij, R; Yanaba, N; Yang, X | 1 |
| Cernelc, P; Podgornik, H; Rebersek, K | 1 |
| Ebara, K; Ichimura, E; Miyakawa, Y; Miyazaki, O; Morino, T; Nagai, D; Nakajima, N; Okamoto, K; Onda, T; Sekine, K | 1 |
| Ding, J; Iida, S; Inagaki, A; Inagaki, H; Ishida, T; Ito, A; Kayukawa, S; Komatsu, H; Kusumoto, S; Mori, F; Nakagawa, C; Oguri, T; Ri, M; Sanda, T; Suzuki, A; Ueda, R; Yano, H | 1 |
| Cao, Z; Li, X; Li, Z; Lin, H; Qian, Z; Wei, Y; Xu, Y; Zhao, Y | 1 |
| Anderson, KC; Burger, R; Catley, L; Chauhan, D; Denis, L; Hideshima, T; Munshi, NC; Podar, K; Richardson, P; Shringarpure, R; Son, MT; Tai, YT; Tassone, P | 1 |
| Hradcová, M; Marinov, I; Nemcová, J; Novák, JT; Stöckbauer, P | 1 |
7 other study(ies) available for camptothecin and Kahler Disease
| Article | Year |
|---|---|
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival.
Topics: Animals; Camptothecin; Cell Adhesion; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Humans; Integrin alpha4beta1; Melphalan; Mice; Mice, Inbred C57BL; Multiple Myeloma; Nanoparticles; Topoisomerase I Inhibitors | 2021 |
Evaluation of multiple myeloma cell apoptosis in primary bone marrow samples.
Topics: ADP-ribosyl Cyclase 1; Apoptosis; Arsenic Trioxide; Arsenicals; Bone Marrow; Camptothecin; Female; Flow Cytometry; Humans; Immunophenotyping; Male; Multiple Myeloma; Oxides; Syndecan-1 | 2013 |
Antimyeloma activity of NK012, a micelle-forming macromolecular prodrug of SN-38, in an orthotopic model.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Irinotecan; Mice; Mice, Inbred NOD; Mice, SCID; Micelles; Multiple Myeloma; Prodrugs; Xenograft Model Antitumor Assays | 2014 |
Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylesterase; Cell Line, Tumor; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Irinotecan; Male; Mice; Mice, SCID; Multiple Myeloma; Topoisomerase I Inhibitors; Transfection; Xenograft Model Antitumor Assays | 2008 |
Camptothecin nanocolloids based on N,N,N-trimethyl chitosan: efficient suppression of growth of multiple myeloma in a murine model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Colloids; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Female; Mice; Mice, Inbred BALB C; Multiple Myeloma; Nanoparticles; Solubility; Time Factors; Topoisomerase I Inhibitors; Tumor Burden | 2012 |
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Boronic Acids; Bortezomib; Camptothecin; Cell Communication; Cell Line, Tumor; DNA Topoisomerases, Type I; DNA, Neoplasm; Doxorubicin; Drug Synergism; Enzyme Activation; fas Receptor; Humans; Irinotecan; JNK Mitogen-Activated Protein Kinases; Lymphoma; Multiple Myeloma; Poly(ADP-ribose) Polymerases; Proteasome Endopeptidase Complex; Pyrazines; Signal Transduction; Stromal Cells; Up-Regulation | 2004 |
Monoclonal antibody to human chronic myeloid leukemia cell line MOLM-7 specifically reacts with an antigen of apoptotic cells.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; DNA, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred BALB C; Multiple Myeloma; Necrosis; Propidium; Tumor Cells, Cultured | 2002 |